Literature DB >> 7942325

Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis.

E González1, C de la Cruz, R de Nicoläs, J Egido, G Herrero-Beaumont.   

Abstract

Most of the previous studies dealing with the effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on the synthesis of inflammatory mediators involved in joint damage have been done in cells cultured in vitro or in blood cells from patients treated for short periods of time. In this work we have evaluated the long-term effect of aceclofenac, a new NSAID, and diclofenac on the production of a series of inflammatory mediators by blood cells from 30 patients with severe knee osteoarthritis. Both aceclofenac and diclofenac significantly inhibited prostaglandin E2 (PGE2) synthesis by blood mononuclear and polymorphonuclear cells after 180 days of treatment. However, no clear effect was noted on leukotriene B4 (LTB4) and platelet activating factor (PAF) production. The generation of O-2 by polymorphonuclear cells, stimulated with FMLP, was decreased after 15 days of treatment with both drugs, but reached normal values after 180 days. Interleukin-1 beta (IL-1 beta) production decreased significantly at 180 days with both drugs in the group of high producer patients. In a few (n = 3) patients with high basal mononuclear cell tumor necrosis factor alpha (TNF alpha) production, this also decreased on treatment for 180 days with the NSAIDs. In the remaining low TNF alpha-producing patients, TNF alpha production tended to increase. Interleukin-6 (IL-6) synthesis was not affected by aceclofenac while it was diminished by diclofenac. The decrease in IL-6 in all treated patients was significantly correlated with a worsening of the clinical condition. On the whole, these data could afford a pathogenetic basis for the long-term employment of these drugs in patients with inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942325     DOI: 10.1007/bf02001912

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  33 in total

1.  Structural analysis of purified platelet-activating factor by lipases.

Authors:  J Benveniste; J P Le Couedic; J Polonsky; M Tence
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

2.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

3.  Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids.

Authors:  M L Blank; F Snyder
Journal:  J Chromatogr       Date:  1983-04-08

4.  Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.

Authors:  J H Sisson; S M Prescott; T M McIntyre; G A Zimmerman
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

5.  Nonsteroidal antiinflammatory agents inhibit upregulation of CD11b, CD11c, and CD35 in neutrophils stimulated by formyl-methionine-leucine-phenylalanine.

Authors:  R E Crowell; D E Van Epps
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

6.  NSAID induction of interleukin 1/catabolin inhibitor production by osteoarthritic synovial tissue.

Authors:  J H Herman; W G Sowder; E V Hess
Journal:  J Rheumatol Suppl       Date:  1991-02

7.  Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages.

Authors:  A Dulioust; E Vivier; N Meslier; R Roubin; I Haye-Legrand; J Benveniste
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

8.  Modulation of IL-1 inflammatory and immunomodulatory properties by IL-6.

Authors:  B Hauptmann; J Van Damme; J M Dayer
Journal:  Eur Cytokine Netw       Date:  1991 Jan-Feb       Impact factor: 2.737

9.  The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes.

Authors:  D M Chang; P Baptiste; P H Schur
Journal:  J Rheumatol       Date:  1990-09       Impact factor: 4.666

10.  Some nonsteroidal antiinflammatory drugs inhibit the generation of superoxide anions by activated polymorphs by blocking ligand-receptor interactions.

Authors:  J O Minta; M D Williams
Journal:  J Rheumatol       Date:  1985-08       Impact factor: 4.666

View more
  13 in total

Review 1.  [Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].

Authors:  G Hein; T Eidner; P Oelzner; B Manger
Journal:  Med Klin (Munich)       Date:  1999-10-15

2.  Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis.

Authors:  D Kornasoff; H Frerick; J Bowdler; E Montull
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

3.  The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A.

Authors:  D A Hartman; S J Ochalski; R P Carlson
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

4.  Effects of flurbiprofen and tiaprofenic Acid on oxidative stress markers in osteoarthritis: A prospective, randomized, open-label, active- and placebo-controlled trial.

Authors:  Sansin Tuzun; Hafize Uzun; Seval Aydin; Ahmet Dinc; Sevtap Sipahi; Mehmet Ata Topcuoglu; Rifat Yucel; Ahmet Belce
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

5.  Efficacy and safety of aceclofenac in osteoarthritis: A meta-analysis of randomized controlled trials.

Authors:  Parvati B Patel; Tejas K Patel
Journal:  Eur J Rheumatol       Date:  2017-03-01

Review 6.  Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.

Authors:  M Dooley; C M Spencer; C J Dunn
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Current pharmacological treatment of osteoarthritis.

Authors:  F A Wollheim
Journal:  Drugs       Date:  1996       Impact factor: 9.546

8.  Psychoneuroimmunological relationships in women with fibromyalgia.

Authors:  Victoria Menzies; Debra E Lyon; R K Elswick; Alison J Montpetit; Nancy L McCain
Journal:  Biol Res Nurs       Date:  2011-12-15       Impact factor: 2.522

9.  Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen.

Authors:  P Sacerdote; M Carrabba; A Galante; R Pisati; B Manfredi; A E Panerai
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

Review 10.  Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management.

Authors:  R N Brogden; L R Wiseman
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.